Has the Safety of Edoxaban 60 mg Among East Asian Atrial Fibrillation Patients Been Truly Proven by the ENGAGE AF-TIMI 48 Subanalysis? - Reply

被引:0
|
作者
Yamashita, Takeshi [1 ]
机构
[1] Cardiovasc Inst, Tokyo, Japan
关键词
VS; WARFARIN; ROCKET AF; RIVAROXABAN;
D O I
10.1253/circj.CJ-16-0653
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:2057 / 2057
页数:1
相关论文
共 33 条
  • [1] Has the Safety of Edoxaban 60 mg Among East Asian Atrial Fibrillation Patients Been Truly Proven by the ENGAGE AF-TIMI 48 Subanalysis?
    Yasumasu, Tomiya
    CIRCULATION JOURNAL, 2016, 80 (09) : 2056 - 2056
  • [2] Edoxaban vs. Warfarin in East Asian Patients With Atrial Fibrillation - An ENGAGE AF-TIMI 48 Subanalysis -
    Yamashita, Takeshi
    Koretsune, Yukihiro
    Yang, Yuejin
    Chen, Shih-Ann
    Chung, Namsik
    Shimada, Yuichi J.
    Kimura, Tetsuya
    Miyazaki, Koichi
    Abe, Kenji
    Mercuri, Michele
    Ruff, Christian T.
    Giugliano, Robert P.
    CIRCULATION JOURNAL, 2016, 80 (04) : 860 - +
  • [3] Efficacy and Safety of Edoxaban in Elderly Patients With Atrial Fibrillation in the ENGAGE AF-TIMI 48 Trial
    Kato, Eri Toda
    Giugliano, Robert P.
    Ruff, Christian T.
    Koretsune, Yukihiro
    Yamashita, Takeshi
    Kiss, Robert Gabor
    Nordio, Francesco
    Murphy, Sabina A.
    Kimura, Tetsuya
    Jin, James
    Lanz, Hans
    Mercuri, Michele
    Braunwald, Eugene
    Antman, Elliott M.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2016, 5 (05):
  • [4] Efficacy and Safety of Edoxaban in Patients With Active Malignancy and Atrial Fibrillation: Analysis of the ENGAGE AF-TIMI 48 Trial
    Fanola, Christina L.
    Ruff, Christian T.
    Murphy, Sabina A.
    Jin, James
    Duggal, Anil
    Babilonia, Noe A.
    Sritara, Piyamitr
    Mercuri, Michele F.
    Kamphuisen, Pieter W.
    Antman, Elliott M.
    Braunwald, Eugene
    Giugliano, Robert P.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2018, 7 (16):
  • [5] Efficacy and safety of edoxaban in patients with diabetes mellitus in the ENGAGE AF-TIMI 48 trial
    Plitt, Anna
    Ruff, Christian T.
    Goudev, Assen
    Morais, Joao
    Ostojic, Miodrag C.
    Grosso, Michael A.
    Lanz, Hans J.
    Park, Jeong-Gun
    Antman, Elliott M.
    Braunwald, Eugene
    Giugliano, Robert P.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2020, 304 : 185 - 191
  • [6] First experience with edoxaban and atrial fibrillation ablation - Insights from the ENGAGE AF-TIMI 48 trial
    Steffel, Jan
    Ruff, Christian T.
    Hamershock, Rose A.
    Murphy, Sabina A.
    Senior, Roxy
    Roy, Denis
    Lanz, Hans-Joachim
    Mercuri, Michele F.
    Antman, Elliott M.
    Giugliano, Robert P.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2017, 244 : 192 - 195
  • [7] Mortality in Patients with Atrial Fibrillation Randomized to Edoxaban or Warfarin: Insights from the ENGAGE AF-TIMI 48 Trial
    Giugliano, Robert P.
    Ruff, Christian T.
    Wiviott, Stephen D.
    Nordio, Francesco
    Murphy, Sabina A.
    Kappelhof, Johannes A. N.
    Shi, Minggao
    Mercuri, Michele F.
    Antman, Elliott M.
    Braunwald, Eugene
    AMERICAN JOURNAL OF MEDICINE, 2016, 129 (08) : 850 - +
  • [8] Efficacy and safety of edoxaban compared with warfarin according to the burden of diseases in patients with atrial fibrillation: insights from the ENGAGE AF-TIMI 48 trial
    Nicolau, Andre M.
    Corbalan, Ramon
    Nicolau, Jose C.
    Ruff, Christian T.
    Zierhut, Wolfgang
    Kerschnitzki, Michael
    Duris, Tibor
    Juul-Moller, Steen
    Voitk, Juri
    Trevisan, Marco
    Nordio, Francesco
    Antman, Elliott M.
    Giugliano, Robert P.
    EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2020, 6 (03) : 167 - 175
  • [9] Edoxaban in atrial fibrillation patients with established coronary artery disease: Insights from ENGAGE AF-TIMI 48
    Zelniker, Thomas A.
    Ruff, Christian T.
    Wiviott, Stephen D.
    Blanc, Jean-Jacques
    Cappato, Riccardo
    Nordio, Francesco
    Mercurio, Michele F.
    Lanz, Hans
    Antman, Elliott M.
    Braunwald, Eugene
    Giugliano, Robert P.
    EUROPEAN HEART JOURNAL-ACUTE CARDIOVASCULAR CARE, 2019, 8 (02) : 176 - 185
  • [10] Edoxaban Use in Nonvalvular Atrial Fibrillation With Valvular Heart DiseaseInsights from ENGAGE AF-TIMI 48
    Owens, Ryan E.
    Kabra, Rajesh
    Oliphant, Carrie S.
    CLINICAL CARDIOLOGY, 2017, 40 (08) : 612 - 613